Cardiac Dys-synchronization and arrhythmia in hyperhomocysteinemia

Current Neurovascular Research

Volumn 4, Issue 4, 2007, Pages 289-294

  Moshal, Karni S ^a   Camel, Clacy K ^a   Kartha, Ganesh K ^a   Steed, Mesia M ^a   Tyagi, Neetu ^a   Sen, Utpal ^a   Kang, Y James ^a   Lominadze, David ^a   Maldonado, Claudio ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Arrhythmia; Bradycardia; Calcium channel; Calpain; Connexin; Contraction; ECM; Endothelial myocyte coupling; Fibrosis; Heart failure; Hypertension; Integrin; LVH; Metabolomics; MMP; NOS; PAR; PPAR; Relaxation; Smooth muscle; Tachycardia; TIMP; Vascular remodeling

Indexed keywords

GAP JUNCTION PROTEIN; HOMOCYSTEINE; MATRIX METALLOPROTEINASE;

CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; HEART ARRHYTHMIA; HEART FUNCTION; HEART PERFORMANCE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SUDDEN DEATH;

ANIMALS; ARRHYTHMIAS, CARDIAC; HEART; HEART FAILURE; HUMANS; HYPERHOMOCYSTEINEMIA; MATRIX METALLOPROTEINASES; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

EID: 36448997797     PISSN: 15672026     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720207782446324     Document Type: Review

References (47)

1. Bhattacharya, A, Cohen, ML. (2000) Vascular contraction and relaxation to thrombin and trypsin: thrombodulin prepernetially attenuates thrombin-induced contraction. J Pharmacol Exp Ther 295: 284-290.
2. Boire, A, Covic, L, Agarwal, A, Jacques, S, Sherifi, S, Kuliopulos, A. (2005) PAR-1 is a matrix metalloproteinase-1 receptor that promotes invasion and tumoigenesis of breast cancer cells. Cell 120: 303-331.
3. Brown, JC, Rosenquist, TH, Monaghan, DT. (1998) ERK-2 activation by homocysteine in vascular smooth muscle cells. Biochem Biophys Res Commun 251 (3): 669-676.
4. Burke, AP, Fonseca, V, Kolodgie, F, Zieske, A, Fink, L, Virmani, R. (2002) Increased serum Hcy and SCD resulting from cornary atherosclerosis with fibrous plaques. Arterioscler Thromb Vasc Biol 22(11): 1936-41.
5. Chapman, HA, Wei, Y. (2001) Protease cross talk with integrins: urokinase receptor paradigm. Thromb Hemostat 86(1): 124-129.
6. D'Amico, M, Di, Filippo, C, Rossi, F, Rossi, F. (1999) Arrhythmias induced by myocardial ischemia-reperfusion are sensitive to ionotrophic excitatory amino acid receptor antagonists. Eur J Pharmacol 366(2-3): 167-74.
7. Davies, B, Brown, PD, East, N, Crimmin, MJ, Balkwill, FR. (1993) A synthetic matrix metalloproteinase inhibitor decreasestumor burden and prolong survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 53(9): 2087-91.
8. Fernandez-Patron, C, Zhang, Y, Radomski, MW, Hollenberg, MD, Davidge, ST. (1999) Rapid release of MMP-2 by thrombin in rat aorta: modulation of protein tyrosine kinase/phosphatase. Thromb Hemost 82: 1353-1357.
9. Fini, ME, Cook, JR, Mohan, R, Brinckerhoff CE. (1998) Regulation of matrix metalloproteinase gene expression, in Parks W, Mechan R (eds): Matrix metalloproteinases. San Diego, CA, Academic Press, pp. 300-356.
10. Fleming, I, Fisslthaler, B, Michaelis, UR, Kiss, L, Popp, R, Busse, R. (2001) The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation in vascular cells. Pflugers Arch 442(4): 511-8.
11. Glading, A, Bodnar, RJ, Reynold, IJ, Shiraha, H, Satish, L, Potter, DA, Blair, HC, Wells, A. (2004) Epidermal Growth Factor Activates m-Calpain (Calpain II), at Least in Part, by Extracellular Signal-Regulated Kinase-Mediated Phosphorylation. Mol Cell Biol 24(6): 2499-2512.
12. Hashimoto, T, Wen, G, Lawton, MT, Boudreau, NJ, Bollen, AW, Yang, GY, Barbaro, NM, Higashida, RT, Dowd, CF, Halbach, VV, Young, WL. (2003) Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke 34(4): 925-931.
13. Hoit, BD, Takeishi, Y, Cox, MJ, Gabel, M, Kirkpatrik, D, Walsh, RA, Tyagi, SC. (2002) Remodeling of the left atrium in pacing-induced cardiomyopathy. Mol Cell Biochem 238: 145-150.
14. Hunt, MJ, Aru, GM, Hayden, MR, Moore, CK, Hoit, BD, Tyagi, SC. (2002) Induction of oxidative stress and disintegrin metalloproteinases in human heart end stage failure. Am J Physiol 283(2): L239-245.
15. Hunt, MJ, Tyagi, SC. (2002) Peroxisome proliferators compete and ameliorate Hcy-mediated endocardial and endothelial cell activation. Am J Physiol 283(4): C1073-C1079.
16. Leoncini, G, Bruzzese, D, Signorello, MG. (2006) Activation of p38 MAPKinase/cPLA2 pathway in homocysteine-treated platelets. J Thromb Haemost 4(1): 209-216.
17. Li, H, Brodsky, S, Kumari, S, Valginijus, V, Brink, P, Kaide, JI, Nasjletti, A, Goligorsky, MS. (2002) Paradoxical overexpression and translocation of connexin-43 in homocysteine treated endothelial cells. Am J Physiol 282: H2124-H2133.
18. Lominadze, D, Roberts, AM, Tyagi, N, Moshal, KS, Tyagi, SC. (2006) Homocysteine causes cerebrovascular leakage in mice. Am J Physiol Heart Circ Physiol 290(3): H1206-13.
19. Loscalzo, J. (2002) Homocysteine and dementias. N Engl J Med 346(7): 466-8.
20. Magazine, HI, King, JM, Srivastava, KD. (1996) Protease activated receptor modulate aortic vascular tone. Int J Cardiol 53(suppl): S75-S80.
21. Majumdar, VS, Hayden, MR, Tyagi, SC. (2000) Homocysteine induces calcium second messenger in vascular smooth muscle cells. J Cell Physiol 183: 28-36.
22. Miller, A, Majumdar, V, Palmer, L, Bower, JD, Tyagi, SC. (2002) Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic. Am J Hypertens 15: 157-163.
23. Miller, A, Majumdar, V, Shek, E, Guillot, J, Angelo, M, Palmer, L, Tyagi, SC. (2000) Hyperhomocyst(e)inemia induces multi-organ damage. Heart Vessels 15(3): 135-43.
24. Mohan, RM, Golding, S, Paterson, DJ. (2001) Intermittent hypoxia modulates nNOS expression and heart rate in response to sympathetic nerve stimulation. Am J Physiol Heart Circ Physiol 281(1): H132-138.
25. Moshal, KS, Sen, U, Tyagi, N, Henderson, B, Steed, M, Ovechkin, AV, Tyagi, SC. (2006) Regulation of Hcy-induced MMP-9 by ERK pathway. Am J Physiol Cell Physiol 290(3): C883-91.
26. Moshal, KS, Tyagi, N, Moss, V, Henderson, B, Steed, B, Ovechkin, AV, Aru, GM, Tyagi, SC. (2005) Early induction of matrix metalloproteinase-9 tranduces signaling in human heart end stage failure. J Cell Mol Med 9 (3): 704-713.
27. Nosaka, S, Murata, K, Kobayashi, M, Cheng, ZB, Maruyama, J. (2002) Inhibition of baroreflex vagal bradycardia by activation of rostra ventro-lateral medulla in rats. Am J Physiol 279: H1239-H1247.
28. Poelzing, S, Rosenbaum, DS. (2004) Altered connexin-43 expression produces arrhythmia substrate in heart failure. Am J Physiol 287: H1762-H1770.
29. Popp, O, Heidinger, M, Heinrich, RL, Ries, C, Jochum, M, Parrado, SG. (2003) The Calpastatin-Derived Calpain Inhibitor CP1B Reduces mRNA Expression of Matrix Metalloproteinase-2 and -9 and Invasion by Leukemic THP-1 Cells. Biol Chem 384: 951-958.
30. Postovit, LM, Dutt, P, Dourdin, N, Greer, PA, Grahm, H, Elce, JS. (2002) Calpain is required for MMP-2 and u-PA expression in SV-40 large T antigen immortalized cells. Biochem Biophys Res Commun 297: 294-301.
31. Rao, JS, Steck, PA, Mohanam, S, Stetler-Stevenson, WG, Liotta, Sawara, R. (1993) Elevated levels of M(r) 92000 type IV collagenase in human brain tumors. Cancer Res 53 (10 suppl): 2208-2211.
32. Sabri, A, Guo, J, Elouardighi, H, Darrow, AL, Andrade-Gordon, P, Steinberg, SG. (2003) Mechanism of PAR-4 actions in cardiomyocytes. Role of Src tyrosine kinase. J Biol Chem 278: 11714-11720.
33. Sato, H, Seiki, M. (1993) Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8: 395-405.
34. Selley, ML. (2004) Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons. J Neurosci Res 77: 90-93.
35. Signorello, MG, Pascale, R, Leoncini, G. (2002) Effect of homocysteine on arachidonic acid release in human platelets. Eur J Clin Invest 32(4): 279-284.
36. Sun, H, Mohri, M, Shimokawa, H, Usui, M, Urakami, L, Takeshita, A. (2002) Coronary microvascular spasm causes myocardial ischemiain patients with vasoplastic angina. J Am Coll Cardiol 39(5): 847-851.
37. Tyagi, N, Sedoris, KC, Moshal, KS, Ovechkin, AV, Tyagi, SC. (2005) Mechanism of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol 289(6): H2649-H2656.
38. Tyagi, SC. (1999) Homocyst(e)ine and heart disease: pathophysiology of extracellular matrix. Clin Exp Hypertens 21: 181-198.
39. Tyagi, SC, Smiley, LM, Majumdar, VS, Clonts, B, Parker, JL. (1998) Reduction-oxidation (redox) and vascular tissue level of homocyst(e)ine in human coronary atherosclerotic lesions and role in vascular extracellular matrix remodeling and vascular tone. Mol Cell Biochem 181: 107-116.
40. Ungravi, Z, Pacher, P, Rischak, K, Szollar, L, Koller, A. (1999) Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocystenimia. Arterioscler Thromb Vasc Biol 19(6): 1899-904.
41. Veeranna, Kaji, T, Boland, B, Odrlijin, T, Mohan, P, Basavarajappa, BS, Peterhoff, C, Cataldo, A, Rudnicki, A, Amin, N, Li, BS, Pant, HC, Hungund, BL, Arancio, O, Nixon, RA. (2004) Calpain mediates calcium-induced activation of ERK-1/2 MAPK pathway and cytoskeleton phosphorylation in neurons. Am J Pathol 165: 795-805.
42. Vliagoftis, H, Schwingshakl, A, Milne, CD, Duszyk, M, Hollenberg, MD, Wallace, JL, Befus, AD, Moqbel, R. (2000) Protease activated receptor-2-mediated matrix metalloproteinase-9 release from airway epithelial cells. J Allergy Clin Immunol 106 (3): 537-45.
43. Vu, TH, Werb, J. (1998) Gelatinase B: structure, regulation and function, in: Matrix Metalloproteinase. WC Parks and RP Mecham (eds) Academic Press: New York, pp. 1-50.
44. Wang, KK, Yuen, PW. (1994) Calpain inhibition: an overview of its therapeutics potential. Trend Pharmacol Sci 15: 412-419.
45. Woessner, JF, Jr. (1998) The matrix metalloproteinase family In: Park WC, Mecham RP, eds. Matrix Metalloproteinase. San Diego, Calif. Academic Press: pp. 1-13.
46. Xu, J, Cui, G, Esmailian, F, Plunkett, M, Marelli, D, Ardehali, A, Odim, J, Liu, H, Sen, L. (2004) Atrial ECM remodeling and maintenance of atrial fibrillation. Circulation 109(3): 363-368.
47. Zhang, C, Cai, Y, Adachi, MT, Oshiro, S, Aso, T, Kaufman, RJ, Kitajima, S. (2001) Homocysteine induces programmed cell death in human vascular endothelial cells through activation of unfolded protein response. J Biol Chem 276: 35867-35874.